Date: June 4, 2021
A pilot open trial of CAMS adapted for adolescents (CAMS-4Teens) with 22 outpatient teens ages 13–17 who presented with elevated suicidality. The model was found feasible, acceptable, and delivered with high clinician adherence, with a large effect-size reduction in suicidal thoughts — preliminary evidence supporting a fully powered trial of CAMS as a frontline treatment for youth at risk.
Authors: Molly Adrian, Jennifer B. Blossom, Phuonguyen V. Chu, David Jobes, Elizabeth MeCauley,
About the Author
David A. Jobes Ph.D. ABPP
David Jobes, PhD, ABPP, is the founder of CAMS-care, LLC. He began his career in 1987 in the Counseling Center of the Catholic University of America, where he developed a suicide risk assessment tool for college students that evolved into CAMS. Dr. Jobes is now a Professor of Psychology and Associate Director of Clinical Training at Catholic; he has trained thousands of mental health professionals in the United States and abroad in evidence-based assessment and treatment of suicide risk and the use of CAMS.